Oxford Biomedica plc (LON:OXB)
London flag London · Delayed Price · Currency is GBP · Price in GBX
571.00
-13.00 (-2.23%)
Jul 24, 2026, 5:12 PM GMT

Oxford Biomedica Revenue

In the year 2025, Oxford Biomedica had annual revenue of 168.74M GBP with 31.01% growth. Oxford Biomedica had revenue of 95.52M in the half year ending December 31, 2025, with 105.51% growth.

Revenue
168.74M
Revenue Growth
+31.01%
P/S Ratio
4.10
Revenue / Employee
172.71K
Employees
977
Market Cap
691.13M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025168.74M39.94M31.01%
Dec 31, 2024128.80M39.26M43.84%
Dec 31, 202389.54M-50.45M-36.04%
Dec 31, 2022139.99M-2.81M-1.97%
Dec 31, 2021142.80M55.07M62.77%
Dec 31, 202087.73M23.67M36.95%
Dec 31, 201964.06M-2.72M-4.07%
Dec 31, 201866.78M29.19M77.65%
Dec 31, 201737.59M9.81M35.33%
Dec 31, 201627.78M11.87M74.59%
Dec 31, 201515.91M2.29M16.82%
Dec 31, 201413.62M8.24M153.36%
Dec 31, 20135.38M-2.38M-30.70%
Dec 31, 20127.76M38.00K0.49%
Dec 31, 20117.72M-3.44M-30.80%
Dec 31, 201011.15M-7.97M-41.67%
Dec 31, 200919.12M726.00K3.95%
Dec 31, 200818.39M11.18M154.80%
Dec 31, 20077.22M6.46M849.87%
Dec 31, 2006760.00K-64.00K-7.77%
Dec 31, 2005824.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Genus672.00M
Oxford Nanopore Technologies223.90M
hVIVO49.66M
Bioventix12.54M
Scancell Holdings4.71M
PureTech Health3.46M
4basebio1.69M
Ondine Biomedical1.43M
Revenue Rankings